United States · 
Who invested in Durata Therapeutics?
Durata Therapeutics's investors include PDL Biopharma.
United States · Funded startup
Who invested in Durata Therapeutics
One round we have observed, with the one investor named in it. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.
Funding summaryUpdated 26 Oct 2026
$70Mraised across 1 round since 2013, from 1 source
- Latest round
- Round, $70MNov 2013
- Investors
- 1
The rounds
- Nov 2013
Exits
ExitBuyerPriceWhen
AcquiredActavis$675MOct 2014
IPONASDAQ:DRTXundisclosedJul 2012
From historical deal records. Wrong? Tell us.
Everyone who backed them
Missing a round, or an investor who was in one? Tell us.
Also claim to have backed them
This firm lists Durata Therapeutics as a portfolio company on their own website, but no report of a round names it. They are the firms' own claims, kept apart from the rounds above.
Quick answers about Durata Therapeutics
How much has Durata Therapeutics raised?
Durata Therapeutics has raised $70M across 1 round since 2013.
When did Durata Therapeutics last raise?
Durata Therapeutics's most recent round was an Undisclosed round of $70M in Nov 2013.
What was Durata Therapeutics's biggest round?
Its most recent round, $70M in Nov 2013, is also its largest on record.
Who backed Durata Therapeutics first?
Durata Therapeutics's first round on record, in Nov 2013, was backed by PDL Biopharma.
What stage is Durata Therapeutics at?
Durata Therapeutics's latest named round is an Undisclosed round, in Nov 2013.
Where is Durata Therapeutics based?
Durata Therapeutics is based in the United States.
Find investors like these
Search every investor by what they have actually funded, then narrow to your stage and market. Free.